|
Sign In to gain access to subscriptions and/or personal tools.
|
Influence of Gender and Genetic Variability on Plasma Angiotensin Peptides
Armando Reyes-Engel
Department of Biochemistry and Molecular Biology Faculty of Medicine. University of Málaga, Spain, engel{at}uma.es
Luis Morcillo
Department of Biochemistry and Molecular Biology Faculty of Medicine. University of Málaga, Spain
Francisco Javier Aranda
Department of Nephrology and Hypertension Unit. Carlos Haya Hospital, Malaga, Spain
Maximiliano Ruiz
Department of Biochemistry and Molecular Biology Faculty of Medicine. University of Málaga, Spain
Maria Jesús Gaitan
Department of Biochemistry and Molecular Biology Faculty of Medicine. University of Málaga, Spain
Álvaro Mayor-Olea
Department of Biochemistry and Molecular Biology Faculty of Medicine. University of Málaga, Spain
Pedro Aranda
Department of Nephrology and Hypertension Unit. Carlos Haya Hospital, Malaga, Spain
Carlos Maria Ferrario
Hypertension and Vascular Disease Center, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA
Introduction. We analysed the influence of three polymorphisms of the renin-angiotensin system (RAS) (I/D from angiotensin-converting enzyme [ACE], M235T from angiotensinogen gene [ATG] and A1166C from AT1 receptors) on plasma levels of angiotensin I (Ang I), angiotensin II (Ang II) and angiotensin-(1-7) [Ang-(1-7)].
Materials and Methods. The study population consisted of a homogeneous group of 93 healthy subjects (43 men and 50 women, mean age: 20.67±2.75 years). The mean blood pressure (BP) was 126±7/76±5 (SD) mmHg and the mean body mass index (SD) mmHg and the mean body mass ' (BMI) was 22.4±2.5 kg/m2. Angiotensin peptides were separated by high performance liquid chromatography (HPLC) and quantified by radio immuno assay (RIA). Genotypes were determined by polymerase chain reaction (PCR) and restriction enzyme analysis.
Results. Mean peptide levels were 92.48±102.12 pg/ml for Ang I, 22.35±10 pg/ml for Ang II, and 31.65±27.46 pg/ml for Ang-(1-7). Men had significantly higher levels of Ang-(1-7) (37.76±36.47 pg/ml) than women (26.04±13.98 pg/ml) (p<0.05). Among genotypes of each polymorphism, men with the T allele showed higher Ang-(1-7) levels compared with those with the MM genotype (p<0.05). Genotype analysis in women showed that higher Ang I levels were related with the DD genotype. When both genders were compared according to genotype, higher values of Ang-(1-7) levels and its molar ratios were found in men, and there was significantly greater Ang I levels in DD genotypes in women than men (136.72±112.43 vs. 65.36±46.83 pg/mL).
Conclusions. Significant correlations were found between Ang I and Ang II as well as between Ang II and Ang-(1-7) in the different study group distributions. No correlation was found between levels of Ang I and Ang-(1- 7). Certain genotypes exert an influence on angiotensin peptide plasma levels which can only be seen when the population is divided according to gender.
Key Words: Human Angiotensin I Angiotensin II and Angiotensin-(1-7) peptide levels I/D angiotensin-converting enzyme A1166C AT1-receptor M235T angiotensinogen Polymorphism
References
- Jeunemaitre X., Soubrier F., Kotelevtsev YV et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992;71:7-20.[Web of Science]
- Bloem LJ, Foroud TM, Ambrosius WT, Hanna MP, Tewksbury DA, Pratt JH Association of the angiotensinogen gene to serum angiotensinogen in blacks and whites. Hypertension 1996;29:1078-82.[Web of Science]
- Bloem LJ, Manatunga AK, Tewksbury DA, Pratt JH The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest 1995;95:948-53.[Web of Science][Medline]
[Order article via Infotrieve]
- Winkelmann BR, Russ AP, Nauck M. et al. Angiotensinogen M235T polymorphism is associated with plasma angiotensinogen and cardiovascular disease. Am Heart J 1999;137:698-705.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6.[Web of Science][Medline]
[Order article via Infotrieve]
- Tiret L., Rigat B., Visvikis S. et al. Evidence from combined segregation and linkage analysis that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51:197-205.[Web of Science][Medline]
[Order article via Infotrieve]
- Danser AH, Deinum J., Osterop AP, Admiraal PJ, Schalekamp MA Angiotensin I to angiotensin II conversion in the human forearm and leg. Effect of the angiotensin converting enzyme gene insertion/deletion polymorphism. J Hypertens 1999;17:1867-72.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Spiering W., Kroon AA, Fuss-Lejeune MM, Daemen MJ, de Leeuw PW Angiotensin II sensitivity is associated with the angiotensin II type 1 receptor A(1166)C polymorphism in essential hypertensives on a high sodium diet. Hypertension 2000;36:411-16.[Abstract/Free Full Text]
- World Health Organisation-International Society of Hypertension. Guidelines for the management of hypertension. J Hypertens 1999;17:151-83.[Web of Science][Medline]
[Order article via Infotrieve]
- American Society of Hypertension. Recommendations for routine blood pressure measurement by indirect cuff sphygmomanometry. Am J Hypertens 1992;5:207-09.[Web of Science][Medline]
[Order article via Infotrieve]
- Rigat B., Hubert C., Corvol P., Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin-converting enzyme gene (DCP1) (dipeptidy1 carboxypeptidase). Nucleic Acids Res 1992;20:1433.[Free Full Text]
- Shanmugan V., Sell KW, Saha BK Mistyping ACE heterozygotes. PCR Methods Applications 1993;3:120-1.[Web of Science][Medline]
[Order article via Infotrieve]
- Russ AP, Maerz W., Ruzicka V., Stein U., Grob W. Rapid detection of the hypertension associated met235-Thr allele of the human angiotensinogen gene. Hum Mol Genet 1993;2:609-10.[Free Full Text]
- Fernandez-Arcas N., Dieguez-Lucena JL, Muñoz-Moran E. et al. The genotype interactions of methylenetetrahydrofolate reductase and renin-angiotensin system genes are associated with myocardial infarction. Atherosclerosis 1999;145:293-300.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Iyer SN, Ferrario CM, Chappell MC Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system. Hypertension 1998;31:356-61.[Abstract/Free Full Text]
- Shimamoto K., Nakagawa M., Iimura O. In vivo concentration of kinins and angiotensins. Horm Metab Res Suppl 1990;22:75-9.[Medline]
[Order article via Infotrieve]
- Matsui T., Tamaya K., Maysumoto K., Osajima Y., Uezono K., Kawasaki T. Plasma concentration of angiotensin metabolites in young male normotensive and mild hypertensive subjects. Hypertens Res 1999;22:273-7.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Gandhi SK, Gainer J., King D., Brown NJ Gender affects renal vasoconstrictor response to Ang I and Ang II. Hypertension 1998;31:90-6.[Abstract/Free Full Text]
- Jalil JE, Palomera C., Ocaranza MP, Godoy I., Roman M., Chiong M., Lavandero S. Levels of plasma angiotensin-(1-7) in patients with hypertension who have the angiotensin-I-converting enzyme deletion/deletion genotype. Am J Cardiol 2003;92(6):749-51.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Sethi AA, Nordestgaard BG, Gronholdt ML, Steffensen R., Jensen G., Tybjaerg-Hansen A. Angiotensinogen single nucleotide polymorphisms, elevated blood pressure, and risk of cardiovascular disease. Hypertension 2003;41:1202-11.[Abstract/Free Full Text]
- Chappell MC, Pirro NT, Sykes A., Ferrario CM Metabolism of angiotensin-(1-7) by angiotensin converting enzyme. Hypertension 1998;31:362-7.[Abstract/Free Full Text]
- Yamada K., Shridhar NI, Chappell MC, Ganten D., Ferrario CM Converting enzyme determines plasma clearance of angiotensin-(1-7). Hypertension 1998;32:496-502.[Abstract/Free Full Text]
- Danser AH, Derkx FH, Schalekamp MA, Hense HW, Riegger GA, Schunkert H. Determinants of interindividual variation of renin and prorrenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans. J Hypertens 1998;16:853-62.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Ferrario CM Angiotensin-(1-7) and antihypertensive mechanisms. J Nephrol 1998;11:278-83.[Web of Science][Medline]
[Order article via Infotrieve]
- Li P., Chappell MC, Ferrario CM, Brosnihan KB Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension 1997;29:394-400.[Abstract/Free Full Text]
- Paula RD, Lima CV, Britto RR, Campagnole-Santos MJ, Khosla MC, Santos RA Potentiation of the hypotensive effect of bradykinin by angiotensin-(1-7)-related peptides. Peptides 1999;20:493-500.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Campbell DJ Differential regulation of angiotensin peptides in plasma and kidney: effects of adrenalectomy and estrogen treatment. Clin Exp Hypertens 1997;19:687-98.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Danser AH, Derkx FH, Hense HW, Jeunemaitre X., Riegger GA, Schunkert H. Angiotensinogen (M235T) and angiotensin-converting enzyme (I/D) polymorphisms in association with plasma renin and prorenin levels. J Hypertens 1998;16:1879-83.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Morgan L., Crawshaw S., Baker PN, Pipkin FB, Kalsheker N. Polymorphism in oestrogen response element associated with variation in plasma angiotensinogen concentrations in healthy pregnant women. J Hypertens 2000;18:553-7.[Web of Science][Medline]
[Order article via Infotrieve]
- Pratt JH, Ambrosius WT, Tewksbury DA, Wagner MA, Zhou L., Hanna MP Serum angiotensinogen concentration in relation to gonadal hormones, body size, and genotype in growing young people. Hypertension 1998;32:875-9.[Abstract/Free Full Text]
- Gallagher PE, Li P., Lenhart JR, Chappell MC, Brosnihan KB Estrogen regulation of angiotensin-converting enzyme mRNA. Hypertension 1999;31:323-8.
- Chappell MC, Diz DI, Yunis C., Ferrario CM Differential actions of angiotensin-(1-7) in the kidney. Kidney Int Suppl 1998;68:S3-S6.[Medline]
[Order article via Infotrieve]
- Paillard F., Chansel D., Brand E. et al. Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population. Hypertension 1999;34:423-9.[Abstract/Free Full Text]
- Roks AJ, van Geel PP, Pinto YM et al. Angiotensin-(1-7) is a modulator of the human renin-angiotensin system. Hypertension 1999;34:296-301.[Abstract/Free Full Text]
- Saris JJ, Van Dijk MA, Kroon I., Schalekamp MA, Danser AH Functional importance of angiotensin-converting enzyme-dependent in situ angiotensin II generation in the human forearm. Hypertension 2000;35:764-8.[Abstract/Free Full Text]
- Ferrario CM, Barnes KL, Block CH et al. Pathways of angiotensin formation and function in the brain. Hypertension 1990;15:113-19.[Web of Science]
- Crackower MA, Sarao R., Oudit GY et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 2002;417:822-8.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Fernandez-Arcas N., Dieguez-Lucena JL, Munoz-Moran E. et al. Both alleles of the M235T polymorphism of the angiotensinogen gene can be a risk factor for myocardial infarction. Clin Genet 2001;60(1):52-7.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Kruse HJ, Wieczorek I., Hecker H., Creutzig A., Schellong SM Seasonal variation of endothelin-1, angiotensin II, and plasma catecholamines and their relation to outside temperature. J Lab Clin Med 2002;140:236-41.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
Journal of Renin-Angiotensin-Aldosterone System, Vol. 7, No. 2,
92-97 (2006)
DOI: 10.3317/jraas.2006.015

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. Ruggenenti, P. Bettinaglio, F. Pinares, and G. Remuzzi
Angiotensin Converting Enzyme Insertion/Deletion Polymorphism and Renoprotection in Diabetic and Nondiabetic Nephropathies
Clin. J. Am. Soc. Nephrol.,
September 1, 2008;
3(5):
1511 - 1525.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Sullivan
Sex and the renin-angiotensin system: inequality between the sexes in response to RAS stimulation and inhibition
Am J Physiol Regulatory Integrative Comp Physiol,
April 1, 2008;
294(4):
R1220 - R1226.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. W. van de Garde, H. Endeman, V. H. M. Deneer, D. H. Biesma, F. A. Sayed-Tabatabaei, H. J. T. Ruven, H. G. M. Leufkens, and J. M. M. van den Bosch
Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Risk and Outcome of Pneumonia
Chest,
January 1, 2008;
133(1):
220 - 225.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|